What can we help you with today?
Filter by Topics
Filter by Category
Found 1365 results
Workspan Daily
03/25/2025
“Keeping an eye on attrition rates and measuring if there has been a notable change after switching work models will help [employers] identify any adjustments to policies or what other benefits they may consider if RTO is the goal.”
Author(s):
Workspan Daily
03/03/2022
.;
After nearly six years of back-and-forth between U.S.
Author(s):
Workspan Daily
07/21/2023
Continuing a Trend Last year, organizations watched as “wave after wave” of pay-transparency laws passed throughout the U.S., said Christine Hendrickson, vice president of strategic initiatives at Syndio.
Author(s):
Workspan Daily
02/08/2024
“After the Supreme Court decision, legal officers are paying closer attention, but programs are being created all the time, so making sure that chief legal officers are aware so they can better consult on these programs is important.”
Author(s):
Press Release
02/07/2022
Telemedicine services, which emerged greatly during the pandemic, stayed commonplace with 97% of organizations offering these programs as part of their health care plan or as a standalone program.
Journal Article
09/15/2022
After all, a stock’s price is influenced by macroeconomic factors and actions clearly outside the control of employees.
Author(s):
Workspan Magazine
02/01/2021
Also, a recent addition to the platform is BumpBenies, a service for new or expectant parents that offers experts in career coaching, nutrition and other support services.
Author(s):
Workspan Magazine
06/11/2025
After spending a week with some of the brightest minds in total rewards at WorldatWork’s
Total Rewards ’25 conference last month, one thing is certain: This profession is not just keeping pace with change — we're leading it.
Author(s):
Site Page
Strategic Leadership: as the VP, Global Head of Corporate Strategic Programs for Bausch Health Company, led operational excellence practice and managed complex global strategic initiatives across all global functions and franchises M&A Expertise: As a partner in PwC’s Deals practice, and as an executive in pharma/life science companies leading integrations/divestitures, extensive experience in due diligence, negotiation, and business integration/carve outs, having worked on more than 75 completed transactions including two corporate inversions ($8.6B Elan/Perrigo and $5.3 Mylan/Abbott EPD) International Partnerships: Leader of global alliance management across multiple operating companies/franchises, actively managed more than 130 strategic relationship for pre-commercial and commercialized assets, including Hub services with over $3B in commercial revenue Expertise and experience in pharmaceutical, life science and medical device industries Stacey received her Bachelor's degree
Workspan Daily
07/01/2025
Developed first to treat diabetes but quickly distinguished for their weight-loss outcomes, the interest in (and popularity of) GLP-1 drugs shows no sign of slowing down today as availability expands and more people — whether it’s a celebrity on the big screen or your neighbor down the street — noticeably shed pounds after using them, said Julie Stich, the vice president of content at the International Foundation of Employee Benefit Plans (IFEBP), an education, research and networking organization.
Author(s):